The synthesis of a novel chalcone and evaluation for anti-free radical activity and antagonizing the learning impairments in Alzheimer's model

Cellular Physiology and Biochemistry

Volumn 29, Issue 5-6, 2012, Pages 949-958

  Pan, Ying ^a   Chen, Yicun ^a   Yu, Xiaoyu ^a   Wang, Jinzhi ^a   Zhang, Lumian ^a   He, Ying ^a   Zheng, Yu ^a   Zheng, Jinhong ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

Alzheimer's; Free radical injury; Hydroxyl substituted chalcones; Polyphenols

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CHALCONE DERIVATIVE; FREE RADICAL; GLUTATHIONE PEROXIDASE; HYDROXYL GROUP; MALONALDEHYDE; POLYPHENOL 3 METHOXY 4, 2' DIHYDROXY 5 BROMO CHALCONE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FINITE ELEMENT ANALYSIS; IN VITRO STUDY; INFRARED SPECTROMETRY; LEARNING DISORDER; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

MUS;

EID: 84861412666     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000188336     Document Type: Article

References (36)

1. Praticò D: Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy. Ann NY Acad Sci 2008;1147:70-78.
2. Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner J C S, Montine TJ: Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol 2009;65:226-229.
3. Carney JM: Oxidative Stress Leading to Loss of Critical Proteases in Alzheimer's Disease: An Alternative View of the Etiology of AD. Ann NY Acad Sci 2000;924:160-163. (Pubitemid 32050197)
4. Simpson JE, Ince PG, Haynes LJ, Theaker RC, Baxter GL, Forster G, Lace GL, Shaw PJ, Matthews FE, Savva GM, Brayne C, Wharton SB: Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol 2010;36:25-40.
5. Hamel E, Nicolakakis N, Aboulkassim T, Ongali B, Tong X-K: Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Exp Physiol 2008;93:116-120. (Pubitemid 350293970)
6. Mecocci P, Mangialasche F, Polidori MC: Oxidative stress in Alzheimer's disease: a selective status report. Neurosci Res Commun 2004;35:202-212. (Pubitemid 40486155)
7. Herrup K: Reimagining Alzheimer's disease-An Age-Based Hypothesis. J Neurosci 2010;30:16755-16766.
8. Kontush A, Schekatolina S: Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease. Ann NY Acad Sci 2004;1031:249-262. (Pubitemid 40361760)
9. Porsolt RD, Lenegre A, Avril I, Doumont G: Antagonism by exifone, a new cognitive enhancing agent of the amnesias induced by four benzodiazepines in mice. Psychopharmacology 1988;95:291-297.
10. Patil CB, Mahajan SK, Katti SA: Chalcone: A Versatile Molecule. J Pharm Sci Res 2009;1:11-22.
11. Maurya DK, Devasagayam TP: Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acid. Food Chem Toxicol 2010;48:3369-3373.
12. Tang LZ, Huang HY, Zhang LM, Zheng JH: Structure-Activity Relationships of 4-hydroxy Cinnamic Acid Derivative to Scavenge Hydroxyl Radical. J Shantou Univ Med Coll 2007;20:8-20.
13. Selgen PO: Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
14. Molyneux P: The use of the stable free radical DPPH for estimating antioxidant activity. Songklanakarin J Sci Technol 2004;26:211-219.
15. Goupy P, Dufour C, Loonis M, Dangles O: Quantitative Kinetic Analysis of Hydrogen Transfer Reactions from Dietary Polyphenols to the DPPH Radical. J Agric Food Chem 2003;51:615-622.
16. Yu F, Xu D, Lei R, Li N, Li K: Free-Radical Scavenging Capacity Using the Fenton Reaction with Rhodamine B as the Spectrophotometric Indicator. J Agric Food Chem 2008;56:730-735. (Pubitemid 351300237)
17. Mitchell DB, Santone KS, Acoata D: Evaluation of cytotoxicity in cultured cells by cnayme leakage. J Tiss Cult Mrth 1980;6:113-116.
18. OECD: Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation. Environmental Health and Safety Monograph Series on Testing and Assessment 2000, No 19.
19. OECD: Guidance Document on Acute Oral Toxicity. Environmental Health and Safety Monograph Series on Testing and Assessment 2000, No. 24.
20. Mirakhur A, Craig D, Hart DJ, McLlroy SP, Passmore AP: Behavioural and psychological syndromes in Alzheimer's disease. International J Ger Psych 2004;19:1035-1039. (Pubitemid 39496930)
21. Snyderab PJ, Bednarb MM, Cromera JR, Maruffcd P: Reversal of scopolamineinduced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor. Alzheimer's & Dementia 2005;1:126-135.
22. Ge YS, Teng WY, Zhang CD: Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells. Chinese Med J 2009;122:716-724.
23. Eckert GP, Cairns NJ, Muller WE: Piracetam reverses hippocampal membrane alterations in Alzheimer's disease. J Neural Transm 1999;106:757-761. (Pubitemid 29401363)
24. Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B: Clinical Efficacy of Piracetam in Cognitive Impairment: A Meta-Analysis. Dementia Geriatr Cogn Disord 2002;13:217-224. (Pubitemid 34507607)
25. Patel A, Smith MT, Cabot PJ: Assessment of working spatial memory utilising Tmaze and Morris water-maze for the study of a rodent model of alzheimer's disease. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane 2004;255.
26. Chen WM, Guo HX: The Effect of Substituted Groups in Benzen Ring on the Condensation Reaction of Acetophenones with Benzaldehydes. Chinese J Synth Chem 1999;7:422-426.
27. 2 /EtOH: Catalytic system for synthesis of chalcones. Catalysis Communications 2008;9:315-316.
28. Xu Q, Yang ZG, Yin DL, Zhang F: Synthesis of chalcones catalyzed by a novel solid sulfonic acid from bamboo. Catalysis Communications 2008;9:1579-1582.
29. McNamara RK, Skelton RW: The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Rev 1993;18:33-49. (Pubitemid 23090010)
30. Morris RG, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-683. (Pubitemid 12096189)
31. Paylor R, Rudy JW: Cholinergic receptor blockade can impair the rat's performance on both place learning and cued versions of the Morris water task: the role of age and pool wall brightness. Behav Brain Res 1990;36:79-90. (Pubitemid 20026607)
32. Saucier D, Hargreaves EL, Boon F, Vanderwolf CH, Cain DP: Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits. Behav Neurosci 1996;110:103-116. (Pubitemid 26068799)
33. Klinkenberg I, Blokland A: The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci Biobehav Rev 2010;34:1307-1350.
34. Cozzolino R, Guaraldi D, Giuliani A, Ghirardi O, Ramacci MT, Angelucci L: Effects of concomitant nicotinic and muscarinic blockade on spatial memory disturbances in rats are purely additive: evidence from the Morris water task. Physiol Behav 1994;56:111-114. (Pubitemid 24223348)
35. Spinelli S, Ballard T, Feldon J, Higgins G. A, Pryce CR: Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys. Neuropharmacol 2006;51:238-250. (Pubitemid 44061881)
36. Larrey D, Biclet P, Razafimahaleo A, Degott C, Devergie B, Babany G, Mosnier JF, Scoazec JY, Feldmann G, Pessayre D: Hepatitis probably caused by exifone (Adlone). Gastroenterol Clin Biol 1989;13:4.